Money Info - Stock Market Headlines - Stock Quotes and Charts - Stock Exchange News and Prices
            

Bioheart, Inc. - Common Stock

Stock Symbol:BHRT

Public, NASDAQ:BHRT

NASDAQ Global Market

BHRT Stock Charts


Bioheart Announces 35 Leading US Heart Failure Centers Engaged In Phase II/III Marvel Trial Of Myogenic Cells For Treating Advanced Heart Failure
Date: Wed, 01 Oct 2008 07:26:44 GMT

Tags:

Bioheart Announces 35 Leading US Heart Failure Centers Engaged In Phase II/III Marvel Trial Of Myogenic Cells For Treating Advanced Heart Failure
Medical News Today (press release) - Oct 1, 2008
Bioheart , Inc . , ( Nasdaq : BHRT ) , announced that 35 of the leading US Heart Failure Centers have engaged in Bioheart's Phase II / III MARVEL ( 1 ) Trial of myogenic cells for treating advanced ...

Bioheart Announces 35 Leading US Heart Failure Centers Engaged in Phase II/III Marvel Trial of Myogenic Cells for Treating Advanced Heart Failure
Date: Tue, 30 Sep 2008 14:01:24 GMT

Tags:

Bioheart Announces 35 Leading US Heart Failure Centers Engaged in Phase II/III Marvel Trial of Myogenic Cells for Treating Advanced Heart Failure
MarketWatch - Sep 30, 2008
, , ) , today announced that 35 of the leading US Heart Failure Centers have engaged in Bioheart's Phase II / III MARVEL ( 1 ) Trial of myogenic cells for treating advanced heart failure." With ...

Bioheart Reports Promising Results From Preclinical Study Of Adipose Derived Acute Cell Therapy
Date: Sat, 27 Sep 2008 07:22:01 GMT

Tags:

Bioheart Reports Promising Results From Preclinical Study Of Adipose Derived Acute Cell Therapy
Medical News Today (press release) - Sep 27, 2008
A preclinical study involving the injection of adipose - derived stem cells ( ADSCs ) into the myocardium ( heart muscle tissue ) of infarcted rats , was recently completed at the Jordan University ...

Bioheart Reports Promising Results From Preclinical Study of Adipose-Derived Acute Cell Therapy
Date: Sun, 21 Sep 2008 18:45:04 GMT

Tags:

Bioheart Reports Promising Results From Preclinical Study of Adipose-Derived Acute Cell Therapy
PipelineReview.com (press release) - Sep 21, 2008
SUNRISE , FL , USA | September 18 , 2008 | A preclinical study involving the injection of adipose - derived stem cells ( ADSCs ) into the myocardium ( heart muscle tissue ) of infarcted rats ...

Bioheart Reports Promising Results From Preclinical Study of Adipose-Derived Acute Cell Therapy
Date: Fri, 19 Sep 2008 12:49:14 GMT

Tags:

Bioheart Reports Promising Results From Preclinical Study of Adipose-Derived Acute Cell Therapy
PharmaLive.com (press release) - Sep 19, 2008
SUNRISE , Fla . , September 18 , 2008 / PRNewswire / - - A preclinical study involving the injection of adipose - derived stem cells ( ADSCs ) into the myocardium ( heart muscle tissue ) of infarcted ...

RedChip Announces Virtual Small-Cap Investor Forum VI: Partnering With Performance (GlobeNewswire)
Date: Mon, 6 Oct 2008 17:51:04 Etc/GMT

Tags:


Bioheart Announces 35 Leading U.S. Heart Failure Centers Engaged in Phase II/III Marvel Trial of Myogenic Cells for Treating Advanced Heart Failure (PR Newswire)
Date: Tue, 30 Sep 2008 13:45:00 Etc/GMT

Tags:


BIOHEART, INC. Files SEC form 8-K, Change in Directors or Principal Officers (EDGAR Online)
Date: Fri, 26 Sep 2008 20:34:31 Etc/GMT

Tags:


Bioheart Reports Promising Results From Preclinical Study of Adipose-Derived Acute Cell Therapy (PR Newswire)
Date: Thu, 18 Sep 2008 21:04:00 Etc/GMT

Tags:

A preclinical study involving the injection of adipose-derived stem cells into the myocardium of infarcted rats, was recently completed at the Jordan University of Science and Technology in Irbid, Jordan by medical and veterinary doctors from that institution and the University of Jordan in Amman, Jordan.
Bioheart, Inc., Announces Presentations at Fall Scientific Meetings (PR Newswire)
Date: Tue, 16 Sep 2008 14:57:00 Etc/GMT

Tags:


Money Info Provides Stock Market Headlines, Stock Quotes and Charts, Stock Exchange News and Prices.
Nasdaq  Dow Jones  BigCharts  E*Trade  ScotTrade

© 2006 - 2008 MONEY INFO. ALL RIGHTS RESERVED.